Definitions for Coronavirus Disease 2019 Reinfection, Relapse and PCR Re-positivity

Overview

Journal Clin Microbiol Infect

Publisher Elsevier

Specialty Infectious Diseases

Date 2020 Dec 7

PMID 33285276

Citations 114

Authors

Dafna Yahav

Dana Yelin

Isabella Eckerle

Christiane S Eberhardt

Jianwei Wang

Bin Cao

Laurent Kaiser

Affiliations

Soon will be listed here.

Citing Articles

An online survey among convalescents 5 months post SARS-CoV-2 infection in China.

Wang Y, Liu M, Guo Y, Li M, Guo P, He W Biosaf Health. 2025; 6(4):206-215.

PMID: 40078662 PMC: 11894947. DOI: 10.1016/j.bsheal.2024.06.001.

Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China.

Qiu C, Lin X, Zhang Q, Chen Y, Su X, Zhang M BMC Infect Dis. 2025; 25(1):173.

PMID: 39910482 PMC: 11800548. DOI: 10.1186/s12879-025-10509-1.

Long-term effectiveness of an ultra-rapid rollout vaccination campaign with BNT162b2 on the incidence of SARS-CoV-2 infection.

Tschiderer L, Innerhofer H, Seekircher L, Waltle L, Richter L, Kimpel J iScience. 2024; 27(11):111117.

PMID: 39555399 PMC: 11567098. DOI: 10.1016/j.isci.2024.111117.

End-to-end SARS-CoV-2 transmission risks in sport: Current evidence and practical recommendations.

Jones B, Phillips G, Valeriani F, Edwards T, Adams E, Bonadonna L S Afr J Sports Med. 2024; 33(1):v33i1a11210.

PMID: 39498368 PMC: 11534289. DOI: 10.17159/2078-516X/2021/v33i1a11210.

Effectiveness of the First and Second Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Dose: A Nationwide Cohort Study From Austria on Hybrid Versus Natural Immunity.

Chalupka A, Riedmann U, Richter L, Chakeri A, El-Khatib Z, Sprenger M Open Forum Infect Dis. 2024; 11(10):ofae547.

PMID: 39371370 PMC: 11450622. DOI: 10.1093/ofid/ofae547.

References

Alter G, Seder R . The Power of Antibody-Based Surveillance. N Engl J Med. 2020; 383(18):1782-1784. PMC: 7484745. DOI: 10.1056/NEJMe2028079. View

Payne D, Iblan I, Rha B, Alqasrawi S, Haddadin A, Al Nsour M . Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus. Emerg Infect Dis. 2016; 22(10):1824-6. PMC: 5038413. DOI: 10.3201/eid2210.160706. View

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

Gousseff M, Penot P, Gallay L, Batisse D, Benech N, Bouiller K . Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?. J Infect. 2020; 81(5):816-846. PMC: 7326402. DOI: 10.1016/j.jinf.2020.06.073. View

Goldman J, Wang K, Roltgen K, Nielsen S, Roach J, Naccache S . Reinfection with SARS-CoV-2 and Waning Humoral Immunity: A Case Report. Vaccines (Basel). 2023; 11(1). PMC: 9861578. DOI: 10.3390/vaccines11010005. View

Larson D, Brodniak S, Voegtly L, Cer R, Glang L, Malagon F . A Case of Early Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020; 73(9):e2827-e2828. PMC: 7543357. DOI: 10.1093/cid/ciaa1436. View

Huang A, Garcia-Carreras B, Hitchings M, Yang B, Katzelnick L, Rattigan S . A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity. Nat Commun. 2020; 11(1):4704. PMC: 7499300. DOI: 10.1038/s41467-020-18450-4. View

Tillett R, Sevinsky J, Hartley P, Kerwin H, Crawford N, Gorzalski A . Genomic evidence for reinfection with SARS-CoV-2: a case study. Lancet Infect Dis. 2020; 21(1):52-58. PMC: 7550103. DOI: 10.1016/S1473-3099(20)30764-7. View

Mo H, Zeng G, Ren X, Li H, Ke C, Tan Y . Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance. Respirology. 2006; 11(1):49-53. PMC: 7192223. DOI: 10.1111/j.1440-1843.2006.00783.x. View

10.

Koyama T, Platt D, Parida L . Variant analysis of SARS-CoV-2 genomes. Bull World Health Organ. 2020; 98(7):495-504. PMC: 7375210. DOI: 10.2471/BLT.20.253591. View

11.

Lu J, Peng J, Xiong Q, Liu Z, Lin H, Tan X . Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR. EBioMedicine. 2020; 59:102960. PMC: 7444471. DOI: 10.1016/j.ebiom.2020.102960. View

12.

Edridge A, Kaczorowska J, Hoste A, Bakker M, Klein M, Loens K . Seasonal coronavirus protective immunity is short-lasting. Nat Med. 2020; 26(11):1691-1693. DOI: 10.1038/s41591-020-1083-1. View

13.

Iwasaki A . What reinfections mean for COVID-19. Lancet Infect Dis. 2020; 21(1):3-5. PMC: 7550040. DOI: 10.1016/S1473-3099(20)30783-0. View

14.

To K, Hung I, Ip J, Chu A, Chan W, Tam A . Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing. Clin Infect Dis. 2020; 73(9):e2946-e2951. PMC: 7499500. DOI: 10.1093/cid/ciaa1275. View

15.

Singanayagam A, Patel M, Charlett A, Lopez Bernal J, Saliba V, Ellis J . Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Euro Surveill. 2020; 25(32). PMC: 7427302. DOI: 10.2807/1560-7917.ES.2020.25.32.2001483. View